Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S.

BMJ. 2010 Jul 7;341:c2701. doi: 10.1136/bmj.c2701.

2.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

3.

Interventions for idiopathic intracranial hypertension.

Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD003434. doi: 10.1002/14651858.CD003434.pub3. Review.

PMID:
26250102
4.

Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.

Dinkin MJ, Patsalides A.

J Neuroophthalmol. 2017 Jun;37(2):113-121. doi: 10.1097/WNO.0000000000000426.

PMID:
27556959
5.

Idiopathic intracranial hypertension.

Digre KB.

BMJ. 2010 Jul 7;341:c2836. doi: 10.1136/bmj.c2836. No abstract available.

PMID:
20610513
6.

Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.

Optical Coherence Tomography Substudy Committee; NORDIC Idiopathic Intracranial Hypertension Study Group.

Ophthalmology. 2015 Sep;122(9):1939-45.e2. doi: 10.1016/j.ophtha.2015.06.003. Epub 2015 Jul 18.

7.

OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.

Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP.

Clin Neurol Neurosurg. 2015 Mar;130:122-7. doi: 10.1016/j.clineuro.2014.12.021. Epub 2015 Jan 7.

PMID:
25614195
8.

Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study.

Skau M, Sander B, Milea D, Jensen R.

J Neurol. 2011 Feb;258(2):277-83. doi: 10.1007/s00415-010-5750-x. Epub 2010 Sep 19.

PMID:
20853113
9.

Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.

Wall M, Thurtell MJ; NORDIC Idiopathic Intracranial Hypertension Study Group.

Br J Ophthalmol. 2017 Sep;101(9):1256-1260. doi: 10.1136/bjophthalmol-2016-309852. Epub 2017 Jan 27.

PMID:
28130349
10.

Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.

Heckmann JG, Faschingbauer F, Lang C, Reulbach U, Dütsch M, Mardin CY, Schwab S.

J Neurosurg. 2007 Sep;107(3):543-7.

PMID:
17886553
11.

Idiopathic intracranial hypertension without papilledema.

Marcelis J, Silberstein SD.

Arch Neurol. 1991 Apr;48(4):392-9.

PMID:
2012512
12.

Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome.

Cinciripini GS, Donahue S, Borchert MS.

Am J Ophthalmol. 1999 Feb;127(2):178-82.

PMID:
10030560
13.

Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach.

Vaidya NS, Mahmoud AM, Buzzacco D, Katz SE.

Orbit. 2016 Oct;35(5):271-7. doi: 10.1080/01676830.2016.1193530. Epub 2016 Aug 10.

PMID:
27541942
14.

Pediatric and adult vision restoration after optic nerve sheath decompression for idiopathic intracranial hypertension.

Bersani TA, Meeker AR, Sismanis DN, Carruth BP.

Orbit. 2016 Jun;35(3):132-9. doi: 10.1080/01676830.2016.1176051. Epub 2016 May 10.

PMID:
27163674
15.

Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Yri HM, Wegener M, Sander B, Jensen R.

J Neurol. 2012 May;259(5):886-94. doi: 10.1007/s00415-011-6273-9. Epub 2011 Oct 19.

PMID:
22008872
17.

Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.

Rebolleda G, Muñoz-Negrete FJ.

Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5197-200. doi: 10.1167/iovs.08-2528. Epub 2008 Nov 14.

PMID:
19011007
18.

Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension.

Mulholland DA, Craig JJ, Rankin SJ.

Br J Ophthalmol. 1998 Nov;82(11):1301-5.

19.

Headache determines quality of life in idiopathic intracranial hypertension.

Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ.

J Headache Pain. 2015;16:521. doi: 10.1186/s10194-015-0521-9. Epub 2015 May 15.

20.

The Relationship Between Optic Nerve Sheath Decompression Failure and Intracranial Pressure in Idiopathic Intracranial Hypertension.

Robinson ME, Moreau A, OʼMeilia R, Pagteilan J, Ding K, Siatkowski RM, Farris BK.

J Neuroophthalmol. 2016 Sep;36(3):246-51. doi: 10.1097/WNO.0000000000000370.

PMID:
27023308

Supplemental Content

Support Center